Clinical trials
Pathologic Complete Response trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2013 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 9 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 18 |
| Unknown status | 10 |
| Completed | 9 |
| Not yet recruiting | 8 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sixth Affiliated Hospital, Sun Yat-sen University | 6 |
| Henan Cancer Hospital | 4 |
| Fudan University | 2 |
| Ming-Yuan Chen | 2 |
| Peking University People's Hospital | 2 |
| Shanghai Pulmonary Hospital, Shanghai, China | 2 |
| Tang-Du Hospital | 2 |
| 307 Hospital of PLA | 1 |
| Anhui Provincial Hospital | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Complete Response | 47 |
| Breast Neoplasms | 13 |
| Rectal Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Head and Neck Neoplasms | 4 |
| Esophageal Squamous Cell Carcinoma | 3 |
| Nasopharyngeal Carcinoma | 3 |
| Neoplasm, Residual | 2 |
| Ovarian Neoplasms | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
Trials
Showing 26 to 47 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.